Recently abused β-keto derivatives of 3,4- methylenedioxyphenylalkylamines: A review of their metabolisms and toxicological analysis

Forensic Toxicology

Volumn 29, Issue 2, 2011, Pages 73-84

  Zaitsu, Kei ^a   Katagi, Munehiro ^a   Tatsuno, Michiaki ^a   Sato, Takako ^b   Tsuchihashi, Hitoshi ^b   Suzuki, Koichi ^b  

^a Chuo ward   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Keto 3,4 methylenedioxyphenylalkylamines; bk MBDB; bk MDEA; bk MDPAs; Designer drug; Methylone

Indexed keywords

(BENZODIFURANYL)AMINOALKANE; 2,5 DIMETHOXYPHENYLALKYLAMINE; BETA KETO 2 ETHYLAMINO 1 (3,4 METHYLENEDIOXYPHENYL)PROPAN 1 ONE; BETA KETO 2 METHYLAMINO 1 (3,4 METHYLENEDIOXYPHENYL)BUTAN 1 ONE; BETA KETO 3,4 METHYLENEDIOXYPHENYLALKYLAMINE DERIVATIVE; BETA KETO PHENYLALKYLAMINE; METHOXYPHENYLALKYLAMINE; METHYLONE; PHENYLALKYLAMINE; TRIMETHOXYPHENYLALKYLAMINE; UNCLASSIFIED DRUG;

DRUG METABOLISM; DRUG STRUCTURE; FORENSIC TOXICOLOGY; HUMAN; HYDROLYSIS; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; METABOLITE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 79960609138     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-011-0111-8     Document Type: Review

References (43)

1. Shulgin AT (1978) Psychotomimetic drugs: structure-activity relationships. In: Iversen LL, Iversen SD, Snyder SH (eds) The handbook of psychopharmacology: stimulants, vol 11. Plenum, New York, pp 243-333
2. JF Buchanan CR Brown 1988 'Designer Drugs' a problem in clinical toxicology Med Toxicol Adverse Drug Exp 3 1 17 3285124 1:CAS:528: DyaL1cXhvFOlsrc%3D (Pubitemid 18078193)
3. Glennon RA (1989) Stimulus properties of hallucinogenic phenylalkylamines and related designer drugs: formulation of structure-activity relationships. In: Asghar K, Souza ED (eds) Pharmacology and toxicology of amphetamine and related designer drugs. NIDA Research Monograph 94, Superintendent of Documents, U.S. Government Printing Office, Washington D.C., pp 43-67 (Pubitemid 20091160)
4. TA Dal Cason R Young RA Glennon 1997 Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogues Pharmacol Biochem Behav 58 1109 1116 9408221 10.1016/S0091-3057(97)00323-7 1:CAS:528:DyaK2sXnvFemtrs%3D (Pubitemid 28108223)
5. 2A receptor J Med Chem 41 5148 5149 9857084 10.1021/jm9803525 1:CAS:528:DyaK1cXnsFKnsbg%3D (Pubitemid 29016308)
6. N Uchiyama R Kikura-Hanajiri N Kawahara Y Goda 2009 Identification of a cannabimimetic indole as a designer drug in a herbal product Forensic Toxicol 27 61 66 10.1007/s11419-009-0069-y 1:CAS:528:DC%2BD1MXos1Cgsrs%3D
7. T Kamata M Katagi H Tsuchihashi 2010 Metabolism and toxicological analyses of hallucinogenic tryptamine analogues being abused in Japan Forensic Toxicol 28 1 8 10.1007/s11419-009-0087-9 1:CAS:528:DC%2BC3cXhtleit74%3D
8. K Zaitsu M Katagi H Kamata K Nakanishi N Shima T Kamata H Nishioka A Miki M Tatsuno H Tsuchihashi 2010 Simultaneous analysis of six novel hallucinogenic (tetrahydrobenzodifuranyl)aminoalkanes (FLYs) and (benzodifuranyl)aminoalkanes (DragonFLYs) by GC-MS, LC-MS, and LC-MS-MS Forensic Toxicol 28 9 18 10.1007/s11419-009-0083-0 1:CAS:528:DC%2BC3cXhtleit78%3D
9. I Vardakou C Pistos Ch Spiliopoulou 2010 Spice drugs as a new trend: mode of action, identification and legislation Toxicol Lett 197 157 162 20566335 10.1016/j.toxlet.2010.06.002 1:CAS:528:DC%2BC3cXptVagu7w%3D
10. Jacob P, Shulgin AT (1996) Preparation of novel N-substituted-2-amino- 3′,4′-methylenedioxypropiophenones as anti-depressant and anti-parkinsonism agents. PCT International Applications, p 19
11. NV Cozzi MK Sievert AT Shulgin P Jacob AE Ruoho 1998 Methcathinone and 2-methylamino-1-(3,4-methylenedioxyphenyl)propan-1-one (methylone) selectively inhibit plasma membrane catecholamine-reuptake transporters Soc Neurosci Abstr 24 381 388
12. NV Cozzi MK Sievert AT Shulgin P Jacob 1999 Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines Eur J Pharmacol 381 63 69 10528135 10.1016/S0014-2999(99)00538-5 1:CAS:528:DyaK1MXmvVKitbg%3D (Pubitemid 29488590)
13. MG Bossong JP Van Dijk RJ Niesink 2005 Methylone and mCPP, two new drugs of abuse? Addict Biol 10 321 323 16318952 10.1080/13556210500350794 1:CAS:528:DC%2BD2MXht1Glt7jP (Pubitemid 41759265)
14. Erowid (2010) The vaults of Erowid. http://www.erowid.org/chemicals/ methylone/methylone-info1.shtml. Accessed Dec 2010
15. M Russell J Sibley J Bunyan 2010 Methylone found in New Zealand party pills TIAFT Bull 40 38 39
16. HT Kamata N Shima K Zaitsu T Kamata A Miki M Nishikawa M Katagi H Tsuchihashi 2006 Metabolism of recently encountered designer drug, methylone, in humans and rats Xenobiotica 36 709 723 16891251 10.1080/00498250600780191 1:CAS:528:DC%2BD28XpsFentbs%3D (Pubitemid 44195985)
17. K Zaitsu M Katagi HT Kamata T Kamata N Shima A Miki H Tsuchihashi Y Mori 2009 Determination of the metabolites of new designer drugs bk-MBDB and bk-MDEA in human urine Forensic Sci Int 188 131 139 19406592 10.1016/j.forsciint.2009. 04.001 1:CAS:528:DC%2BD1MXmtlKgsL8%3D
18. MR Meyer J Wilhelm FT Peters HH Maurer 2010 Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry Anal Bioanal Chem 397 1225 1233 20333362 10.1007/s00216-010-3636-5 1:CAS:528:DC%2BC3cXjsleltrc%3D
19. D Springer G Fritschi HH Maurer 2003 Metabolism and toxicological detection of the new designer drug 3′,4′-methylenedioxy-alpha- pyrrolidinopropiophenone studied in urine using gas chromatography-mass spectrometry J Chromatogr B 793 377 388 10.1016/S1570-0232(03)00350-7 1:CAS:528:DC%2BD3sXlvFGhsr0%3D (Pubitemid 37271978)
20. B Testa AH Beckett 1973 Metabolism and excretion of diethylpropion in man under acidic urine conditions J Pharm Pharmacol 25 119 124 4146542 10.1111/j.2042-7158.1973.tb10604.x 1:STN:280:DyaE3s3islKnsg%3D%3D
21. M Milhailova A Rosen B Testa AH Beckett 1974 A pharmacokinetic investigation of distribution and elimination of diethylpropion and its metabolites in man J Pharm Pharmacol 26 711 721 10.1111/j.2042-7158.1974. tb09355.x
22. R Brenneison K Mathys S Geisshusler 1991 Determination of S-(-)-cathinone and its main metabolites R, S-(-)-norephedrine in human plasma by high-performance liquid chromatography and photodiode array detection J Liq Chromatogr 14 271 286 10.1080/01483919108049614
23. BD Paul KA Cole 2001 Cathinone (Khat) and methcathinone (CAT) in urine specimens J Anal Toxicol 25 525 530 11599595 1:CAS:528:DC%2BD3MXnsVChu7k%3D
24. SW Toennes GF Kauert 2002 Excretion and detection of cathinone, cathine, and phenylpropanolamine in urine after kath chewing Clin Chem 48 1715 1719 12324488 1:CAS:528:DC%2BD38XnsV2hu7Y%3D
25. HK Lim RL Foltz 1989 Identification of metabolites of 3,4-(methylenedioxy)-methamphetamine in human urine Chem Res Toxicol 2 142 143 2577520 10.1021/tx00009a002 1:CAS:528:DyaL1MXktFyqs7s%3D (Pubitemid 19159940)
26. R de la Torre M Farré PN Roset N Pizarro S Abanades M Segura J Segura J Camí 2004 Human pharmacology of MDMA pharmacokinetics, metabolism, and disposition Ther Drug Monit 26 137 144 15228154 10.1097/00007691-200404000-00009 (Pubitemid 38501207)
27. HT Kamata N Shima K Zaitsu T Kamata M Nishikawa M Katagi A Miki H Tsuchihashi 2007 Simultaneous analysis of new designer drug, methylone and its metabolites in urine by gas chromatography-mass spectrometry and liquid chromatography-electrospray ionization mass spectrometry Jpn J Forensic Sci Technol 12 97 106 10.3408/jafst.12.97
28. N Shima H Tsutsumi T Kamata M Nishikawa M Katagi A Miki H Tsuchihashi 2006 Direct determination of glucuronide and sulfate of p-hydroxymethamphetamine in methamphetamine users' urine J Chromatogr B 830 64 70 10.1016/j.jchromb. 2005.10.014 1:CAS:528:DC%2BD2MXhtlCrsLfM (Pubitemid 41831389)
29. N Shima H Kamata M Katagi H Tsuchihashi T Sakuma N Nemoto 2007 Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine J Chromatogr B 857 123 129 10.1016/j.jchromb.2007.07.003 1:CAS:528:DC%2BD2sXhtVWmsLrM (Pubitemid 47364837)
30. BD Berrang AH Lewin CF Ivy 1982 Enantiomeric α-aminopropiophenones (cathinone): preparation and investigation J Org Chem 47 2643 2647 10.1021/jo00134a026 1:CAS:528:DyaL38XktlyksbY%3D (Pubitemid 12008344)
31. Y Togawa T Ohmori K Tanaka T Inoue 1994 Analyses of new stimulants, methcathinone and cathinone Rep Natl Res Inst Police Sci 47 77 84 1:CAS:528:DyaK2MXltVGqu7w%3D (in Japanese with English abstract)
32. K Zaitsu M Katagi HT Kamata A Miki H Tsuchihashi 2008 Discrimination and identification of regioisomeric β-keto analogues of 3,4- methylenedioxyamphetamines by gas chromatography-mass spectrometry Forensic Toxicol 26 45 51 10.1007/s11419-008-0050-1 1:CAS:528:DC%2BD1MXotFKqsA%3D%3D
33. K Zaitsu M Katagi T Kamata H Kamata N Shima H Tsuchihashi T Hayashi H Kuroki R Matoba 2008 Determination of a newly encountered designer drug "p-methoxyethylamphetamine" and its metabolites in human urine Forensic Sci Int 177 77 84 18155375 10.1016/j.forsciint.2007.11.001 1:CAS:528:DC%2BD1cXktV2jsb8%3D
34. K Zaitsu M Katagi H Kamata T Kamata N Shima A Miki T Iwamura H Tsuchihashi 2008 Discrimination and identification of the six aromatic positional isomers of trimethoxyamphetamine (TMA) by gas chromatography-mass spectrometry (GC-MS) J Mass Spectrom 43 528 534 18035853 10.1002/jms.1347 1:CAS:528:DC%2BD1cXltlWktLo%3D (Pubitemid 351518674)
35. K Kanai K Takekawa T Kumamoto T Ishikawa T Ohmori 2008 Simultaneous analysis of six phenethylamine-type designer drugs by TLC, LC-MS, and GC-MS Forensic Toxicol 26 6 12 10.1007/s11419-008-0041-2 1:CAS:528: DC%2BD1cXptFyhsbw%3D
36. K Kudo T Ishida W Hikiji M Hayashida K Uekusa Y Usumoto A Tsuji N Ikeda 2009 Construction of calibration-locking databases for rapid and reliable drug screening by gas chromatography-mass spectrometry Forensic Toxicol 27 21 31 10.1007/s11419-009-0066-1 1:CAS:528:DC%2BD1MXitlGgtLs%3D
37. K Kudo T Ishida W Hikiji Y Usumoto T Umehara K Nagamatsu A Tsuji N Ikeda 2010 Pattern of poisoning in Japan: selection of drugs and poisons for systematic toxicological analysis Forensic Toxicol 28 25 32 10.1007/s11419-009- 0088-8 1:CAS:528:DC%2BC3cXhtleit7g%3D
38. M Morita H Ando 1983 Analysis of methamphetamine and its metabolites in urine from a habitual user of the stimulant EISEI KAGAKU 29 318 322 1:CAS:528:DyaL2cXmt12ktg%3D%3D (in Japanese with English abstract) (Pubitemid 14182126)
39. HH Maurer 2005 Advances in analytical toxicology: the current role of liquid chromatography-mass spectrometry in drug quantification in blood and oral fluid Anal Bioanal Chem 381 110 118 15309372 10.1007/s00216-004-2774-z 1:CAS:528:DC%2BD2MXht1GitL4%3D (Pubitemid 40249210)
40. CA Mueller W Weinmann S Dresen A Schreiber M Gergov 2005 Development of a multi-target screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searching Rapid Commun Mass Spectrom 19 1332 1338 15852450 10.1002/rcm.1934 1:CAS:528:DC%2BD2MXkvVyqsLs%3D (Pubitemid 40728148)
41. S Dresen J Kempf W Weinmann 2006 Electrospray-ionization MS/MS library of drugs as database for method development and drug identification Forensic Sci Int 161 86 91 16860958 10.1016/j.forsciint.2006.02.053 1:CAS:528: DC%2BD28XotFWkt7Y%3D (Pubitemid 44142900)
42. ML Smith SP Vorce JM Holler E Shimomura J Magluilo AJ Jacobs MA Huestis 2007 Modern instrumental methods in forensic toxicology J Anal Toxicol 31 237 253 17579968 1:CAS:528:DC%2BD2sXmtl2isrs%3D (Pubitemid 46911621)
43. M Katagi K Zaitsu N Shima H Kamata T Kamata K Nakanishi H Nishioka A Miki H Tsuchihashi 2010 Metabolism and forensic toxicological analyses of the extensively abused designer drug methylone TIAFT Bull 40 30 34